| Product Name | MF | CAS | Details |
|---|
| Anti-TANK (ab1) antibody produced in rabbit | Details |
| 1,1-DIMETHYL-3-(2,2,2-TRICHLORO-1-(3-(4-IODO-PHENYL)-THIOUREIDO)-ETHYL)-UREA | 883832-95-9 | Details |
| Rb X Neurotensin Receptor Type 1 | Details |
| N-[3-(2,5-dimethylphenoxy)propyl]guanidine, nitrate salt | C12H19N3O.HNO3 | 1784155-29-8 | Details |
| Supelclean Z-Sep/C18 Mixed Bed SPE Tube | Details |
| Atri3GalNAcβ-C3-PAA-fluo | Details |
| R-MOP | C33H25OP | 145964-33-6 | Details |
| 3-(3-FLUOROPHENYL)-N-(2-(4-METHOXYPHENYL)ETHYL)-2-PROPENAMIDE | C18H18FNO2 | 853355-87-0 | Details |
| Bis[4-(3,3,4,4,5,5,5-heptafluoro-2,2-bis(trifluoromethyl)pentyl)phenyl]phenylphosphine | C32H17F26P | 322647-83-6 | Details |
| 8-BROMO-7-HEXYL-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C13H19BrN4O2 | 1225-19-0 | Details |
| N-(4-(4-METHOXYPHENYL)-5-PHENYL-1,3-THIAZOL-2(3H)-YLIDENE)ANILINE HYDROBROMIDE | C22H19BrN2OS | 387833-24-1 | Details |
| 1,1-DIPHENYL-1-DODECENE | C24H32 | 1530-29-6 | Details |
| 4-(2-(((3,4-DICHLOROBENZOYL)AMINO)ACETYL)CARBOHYDRAZONOYL)PHENYL 4-CL-BENZOATE | C23H17Cl3N3O4 | 881403-12-9 | Details |
| Dess-Martin periodinane solution | C13H13IO8 | 87413-09-0 | Details |
| 3-Dodecylthiophene | C16H28S | 104934-52-3 | Details |
| (2E)-3-(hexylamino)-1-(2-hydroxyphenyl)-2-propen-1-one | C15H21NO2 | 14386-70-0 | Details |
| 4-(2-(2-(3-CHLOROPHENOXY)PROPANOYL)CARBOHYDRAZONOYL)PHENYL 2,4-DICHLOROBENZOATE | C23H17Cl3N2O4 | 868391-04-2 | Details |
| (2R)-2-[(2,2-Dimethylpropanoyl)amino]-2-phenylacetic acid | C13H17NO3 | 40610-41-1 | Details |
| Anti-CCDC159 antibody produced in rabbit | Details |
| N-(4-BR-PH)-2-((4-ETHYL-5-(2-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ACETAMIDE | C17H16BrN5OS | 618414-83-8 | Details |
| 6-CHLORO-5-NITRO-2,4(1H,3H)-PYRIMIDINEDIONE | C4H2ClN3O4 | 6630-30-4 | Details |
| FHUP 25MM 100/PK | Details |
| N-(1-ME-2-PYRROLIDINYLIDENE)-N'-PH-4-MORPHOLINECARBOXIMIDAMIDE 2-BUTENEDIOATE | C16H22N4O.C4H4O4 | 1173012-29-7 | Details |
| Anti-Phospho-MAP2K1-S217/MAP2K2-S221 antibody produced in rabbit | Details |
| 3-(N-(3-CHLORO-4-METHYLPHENYL)CARBAMOYL)-1,4,5,6,7,7-HEXA-CL-5-NORBORNENE-2-CO2H | 196876-36-5 | Details |
| 3-CHLORO-N-[2-((2E)-2-{4-METHOXY-3-[(2-PYRIDINYLSULFANYL)METHYL]BENZYLIDENE}HYDRAZINO)-2-OXOETHYL]-1-BENZOTHIOPHENE-2-CARBOXAMIDE | C25H21ClN4O3S2 | 880022-57-1 | Details |
| Anti-Myosin Light Chain Kinase antibody, Mouse monoclonal | Details |
| Bollé Silium metal frame safety spectacles with adjustable non-slip nose bridge & flex temples | Details |
| Monoclonal Anti-LAMC1 antibody produced in mouse | Details |
| Limestone | CCaO3 | 1317-65-3 | Details |
| 5-(2-FLUOROPHENYL)-1-PHENYL-1H-TETRAAZOLE | C13H9FN4 | 438538-26-2 | Details |
| 4-(((3-(2-BROMOPHENYL)-5-MERCAPTO-4H-1,2,4-TRIAZOL-4-YL)IMINO)ME)-2-ETHOXYPHENOL | C17H15BrN4O2S | 500280-05-7 | Details |
| 8-(BENZYL(METHYL)AMINO)-3-METHYL-7-PROPYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C17H21N5O2 | 332904-86-6 | Details |
| 1-(3,7-DIMETHYL-OCTA-2,6-DIENYLOXY)-2,4-DINITRO-BENZENE | C16H20N2O5 | 35162-73-3 | Details |
| BMP Inhibitor II, DMH1 | C24H20N4O | 1206711-16-1 | Details |
| 4,4,6-TRIMETHYL-4,5-DIHYDRO-2,3-DITHIA-5-AZA-CYCLOPENTA(A)NAPHTHALENE-1-THIONE | C13H13NS3 | 122246-14-4 | Details |
| DBX2 Blocking Peptide for SAB3500843 | Details |
| 4-(2-((3-CL-2-METHYLANILINO)(OXO)AC)CARBOHYDRAZONOYL)-2-MEO-PH 3-BROMOBENZOATE | C24H19BrClN3O5 | 477730-20-4 | Details |
| Dithiodiglycolic acid | C4H6O4S2 | 505-73-7 | Details |
| 6-Quinolineboronic acid pinacol ester | C15H18BNO2 | 406463-06-7 | Details |
| Anti-SELENON antibody produced in rabbit | Details |
| Microneedle template | Details |
| Anti-Rabbit IgG?Abberior? STAR 512 antibody produced in goat | Details |
| Omeprazole sulfide 5-carboxylic acid | C17H17N3O4S | 103877-00-5 | Details |
| 8-ACETAMIDO-5-AMINO-6-(METHYLTHIO)QUINOLINE | C12H13N3OS | 134992-40-8 | Details |
| Trichloro(phenethyl)silane | C8H9Cl3Si | 940-41-0 | Details |
| GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
| PrEST Antigen TTLL6 | Details |
| (2,2,6,6-Tetramethyl-3,6-dihydro-2H-pyran-4-yl)boronic acid pinacol ester | C15H27BO3 | 1142363-56-1 | Details |
| 2-{(2E)-2-[2-(ALLYLOXY)BENZYLIDENE]HYDRAZINO}-N-(3-CYANO-4,5,6,7-TETRAHYDRO-1-BENZOTHIEN-2-YL)-2-OXOACETAMIDE | C21H20N4O3S | 880027-76-9 | Details |
| ETHYL 2-{[((2E)-2-{4-[(3,4-DIMETHOXYBENZOYL)OXY]BENZYLIDENE}HYDRAZINO)(OXO)ACETYL]AMINO}-6-METHYL-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE | C30H31N3O8S | 881456-96-8 | Details |
| TETRAETHYL 5,5'-((1Z,4Z)-3-OXOPENTA-1,4-DIENE-1,5-DIYL)BIS(3-METHYL-1H-PYRROLE-2,4-DICARBOXYLATE) | C27H32N2O9 | 892151-48-3 | Details |
| Monoclonal Anti-Grp78 antibody produced in mouse | Details |
| METHYL (2Z)-2-[1-{CYANO[4-(CYANOMETHYL)PHENYL]METHYL}-5-(3-NITROANILINO)-5-OXOPENTYLIDENE]HYDRAZINECARBOXYLATE | C23H22N6O5 | 883815-03-0 | Details |
| Manganese(II) oxide | MnO | 1344-43-0 | Details |
| 2-(3-(4-FLUOROPHENYL)UREIDO)ACETIC (3-HYDROXY-4-METHOXYBENZYLIDENE)HYDRAZIDE | C17H17FN4O4 | 199460-83-8 | Details |
| 2-(4-CHLOROPHENOXY)-N'-(4-NITROBENZYLIDENE)ACETOHYDRAZIDE | C15H12ClN3O4 | 106825-38-1 | Details |
| CP-424,174 | C22H29ClN2O4S | 210825-31-3 | Details |
| 1-(4-CHLOROPHENYL)-3-(1-PIPERIDINYL)-1-PROPANONE HYDROCHLORIDE | C14H19Cl2NO | 5250-05-5 | Details |
| Monoclonal Anti-Amigo-1 - Apc antibody produced in mouse | Details |
| (3Z)-1-(2-CHLOROBENZYL)-3-[3-(3-METHOXYPROPYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]-1,3-DIHYDRO-2H-INDOL-2-ONE | C22H19ClN2O3S2 | 519011-56-4 | Details |
| 2-{(3Z)-3-[3-(1,1-DIOXIDOTETRAHYDRO-3-THIENYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]-2-OXO-2,3-DIHYDRO-1H-INDOL-1-YL}-N-(4-ETHOXYPHENYL)ACETAMIDE ACETATE | C25H23N3O6S3.C2H4O2 | 1173013-77-8 | Details |
| ETHYL 2-AMINO-4-(1,3-BENZODIOXOL-5-YL)-1-(4-FLUOROPHENYL)-7,7-DIMETHYL-5-OXO-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBOXYLATE | 311785-80-5 | Details |
| CUF600 system | Details |
| RW19 Prefilter 257mm 25/PK | Details |
| 1-PHENYLPIPERAZINE DIHYDROCHLORIDE | C10H16Cl2N2 | 4004-95-9 | Details |
| 9-(4-METHYLPHENYL)-2,3-DIHYDROCYCLOPENTA(C)FURO(3,2-G)CHROMEN-4(1H)-ONE | C21H16O3 | 370584-85-3 | Details |
| 2-(1-NAPHTHYL)ACETIC 4-CHLOROBENZYLIDENEHYDRAZIDE | C19H15ClN2O | 67759-88-0 | Details |
| 4,6-Dichloro-5-methylpyrimidine | C5H4Cl2N2 | 4316-97-6 | Details |
| 1-OCTADECYL-3-(2,4-XYLYL)UREA | 200618-78-6 | Details |
| 4-(2-((2-CHLOROPHENOXY)ACETYL)CARBOHYDRAZONOYL)PHENYL 3-CHLOROBENZOATE | C22H16Cl2N2O4 | 868553-26-8 | Details |
| 2-METHOXY-4-((E)-{[10-((2E)-2-{3-METHOXY-4-[(4-METHOXYBENZOYL)OXY]BENZYLIDENE}HYDRAZINO)-10-OXODECANOYL]HYDRAZONO}METHYL)PHENYL 4-METHOXYBENZOATE | C42H46N4O10 | 374686-06-3 | Details |
| PYRIDINIUM-1-ACETATE COMPOUND WITH PYRIDINE HYDROCHLORIDE | Details |
| BugBuster? His?Bind? Purification Kit | Details |
| N,N-Dimethyl-d6-glycine hydrochloride | C4H4ClD6NO2 | 347840-03-3 | Details |
| Fmoc-(R)-2-(7-octenyl)Ala-OH | C26H31NO4 | 945212-26-0 | Details |
| Anti-PI3K antibody produced in chicken | Details |
| (1R,2R)-()-2-Amino-1-phenyl-1,3-propanediol | C9H13NO2 | 46032-98-8 | Details |
| Polyetherketone | Details |
| N-VANILLYLNONANOAMIDE | C17H27NO3 | 2444-46-4 | Details |
| N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-NICOTINAMIDE | C13H15N3O2 | 717855-84-0 | Details |
| GlcNAcβ-Gly-PAA-biot | Details |
| Monoclonal Anti-N-terminal Arginylation-PerCP antibody produced in mouse | Details |
| Naproxen impurity L | C13H12O2 | 3900-45-6 | Details |
| Monoclonal Anti-CA4 antibody produced in mouse | Details |
| Methyl 3-methoxy-2-nitrobenzoate | C9H9NO5 | 5307-17-5 | Details |
| 4-(DIMETHYLAMINO)-N-(4-METHYL-3-NITROPHENYL)BENZYLAMINE | 200130-66-1 | Details |
| PIPERONYL N-(2,6-DICHLOROPHENYL)CARBAMATE | 202599-69-7 | Details |
| 3-((3,4-DI-MEO-BENZYLIDENE)AMINO)-6-ME-5-PHENYLTHIENO(2,3-D)PYRIMIDIN-4(3H)-ONE | C22H19N3O3S | 379245-12-2 | Details |
| D-Amino Acid Oxidase Inhibitor II, CBIO | C7H4ClNO2 | 61977-29-5 | Details |
| Anti-METAP1 (N-term) antibody produced in rabbit | Details |
| Monoclonal Anti-EPHB3, (C-terminal) antibody produced in mouse | Details |
| Custom peptide | Details |
| Dimethomorph | C21H22ClNO4 | 110488-70-5 | Details |
| IgG2a, Kappa from murine myeloma | Details |
| 2-[(3-ALLYL-7-METHYL-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]-N-(2-PHENYLETHYL)ACETAMIDE | C24H27N3O2S2 | 315685-39-3 | Details |
| Poly[1-[4-(3-carboxy-4-hydroxyphenylazo)benzenesulfonamido]-1,2-ethanediyl, sodium salt] | C15H14N3NaO5S | 219957-04-7 | Details |
| N-(3,5-DIMETHOXYPHENYL)-2-{[4-METHYL-5-(3-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}ACETAMIDE | C18H19N5O3S | 557065-57-3 | Details |
| Dihexadecyl disulfide | C32H66S2 | 1561-75-7 | Details |
| Monoclonal Anti-GRM8 antibody produced in mouse | Details |
| Product Total： Product Page： | ||||
| 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 | ||||